Corcept Therapeutics Incorporated CORT was a big mover last session, as its shares rose almost 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally breaks the trend for the company, as the stock is now trading above the volatile price range of $3.87 to $4.48 in the past one-month time frame.
Over the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
Corcept Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A better-ranked med-drugs stock is Calithera Biosciences, Inc. CALA with a Zacks Rank #1 (Strong Buy).
Is CORT going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. CClick to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CORCEPT THERAPT (CORT): Free Stock Analysis Report
CALITHERA BIOSC (CALA): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research